135 related articles for article (PubMed ID: 35004980)
1. Clinical features and survival of patients with multiple primary malignancies.
Wang XK; Zhou MH
World J Clin Cases; 2021 Dec; 9(34):10484-10493. PubMed ID: 35004980
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of multiple primary malignancies: a retrospective analysis of 72 Chinese patients.
Jiao F; Yao LJ; Zhou J; Hu H; Wang LW
Asian Pac J Cancer Prev; 2014; 15(1):331-4. PubMed ID: 24528052
[TBL] [Abstract][Full Text] [Related]
3. A Case Series of Multiple Primary Malignancies Among Patients With Advanced Melanoma.
Ebia MI; Capone S; Ricker C; Thomas JS; Tulpule V; Kang I; D'Souza A; Freyer DR; Miller K; In GK
Cureus; 2021 Jun; 13(6):e15480. PubMed ID: 34262818
[TBL] [Abstract][Full Text] [Related]
4. Multiple primary malignancies involving lung cancer.
Li F; Zhong WZ; Niu FY; Zhao N; Yang JJ; Yan HH; Wu YL
BMC Cancer; 2015 Oct; 15():696. PubMed ID: 26466785
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of Clinical Characteristics of Lung Cancer Combined with
Multiple Primary Malignancies in Other Organs].
Zhang S; Xu Z; Dong G; Li M; Xu L
Zhongguo Fei Ai Za Zhi; 2021 Jan; 24(1):7-12. PubMed ID: 33478184
[TBL] [Abstract][Full Text] [Related]
6. Multiple primary malignancies involving lung cancer: a single-center experience.
Ventura L; Carbognani P; Gnetti L; Rossi M; Tiseo M; Silini EM; Sverzellati N; Silva M; Succi M; Braggio C; Cattadori S; Bocchialini G; Balestra V; Rusca M; Ampollini L
Tumori; 2021 Jun; 107(3):196-203. PubMed ID: 32578517
[TBL] [Abstract][Full Text] [Related]
7. Risk and prediction of multiple primary malignancies after early gastric cancer.
Chen N; Shi L; Ge J; Jia R; Jiang J
Front Oncol; 2023; 13():1205358. PubMed ID: 37560468
[TBL] [Abstract][Full Text] [Related]
8. Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up.
Xu W; Liao W; Ge P; Ren J; Xu H; Yang H; Sang X; Lu X; Mao Y
Medicine (Baltimore); 2016 Apr; 95(17):e3491. PubMed ID: 27124050
[TBL] [Abstract][Full Text] [Related]
9. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
[TBL] [Abstract][Full Text] [Related]
10. Comparison of colorectal and gastric cancer: survival and prognostic factors.
Moghimi-Dehkordi B; Safaee A; Zali MR
Saudi J Gastroenterol; 2009 Jan; 15(1):18-23. PubMed ID: 19568550
[TBL] [Abstract][Full Text] [Related]
11. Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry.
Powell S; Tarchand G; Rector T; Klein M
Cancer Causes Control; 2013 Aug; 24(8):1565-73. PubMed ID: 23737025
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
Xiao Y; Pan J; Chen Y; Lin S; Chen Y; Zong J; Fang Y; Guo Q; Chen B; Tang L
Radiat Oncol; 2015 Sep; 10():204. PubMed ID: 26407897
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
14. Spinal Metastasis in Multiple Primary Malignancies Involving Lung Cancer: Clinical Characteristics and Survival.
Truong VT; Al-Shakfa F; Newman N; Roberge D; Masucci GL; Tran TPY; Boubez G; Shedid D; Yuh SJ; Wang Z
World Neurosurg; 2022 Nov; 167():e726-e731. PubMed ID: 36030008
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
16. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and prognostic features of the patients with esophageal squamous cell carcinomas as a first primary malignancy].
Wen Z; Zhang YQ; Wu R; Peng XM; Chen B; Leng AM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Jul; 37(4):407-414. PubMed ID: 34374262
[No Abstract] [Full Text] [Related]
18. Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up study.
Zeng QA; Qiu J; Zou R; Li Y; Li S; Li B; Huang P; Hong J; Zheng Y; Lao X; Yuan Y
BMC Cancer; 2012 Apr; 12():148. PubMed ID: 22510321
[TBL] [Abstract][Full Text] [Related]
19. Second primary melanomas: incidence and outcome.
Bower MR; Scoggins CR; Martin RC; Mays MP; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Noyes RD; Sussman JJ; Hagendoorn LJ; Stromberg AJ; McMasters K
Am Surg; 2010 Jul; 76(7):675-81. PubMed ID: 20698369
[TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer survival: An analysis of patients with metastatic disease synchronous and metachronous with the primary tumor.
Kumar R; Price TJ; Beeke C; Jain K; Patel G; Padbury R; Young GP; Roder D; Townsend A; Bishnoi S; Karapetis CS
Clin Colorectal Cancer; 2014 Jun; 13(2):87-93. PubMed ID: 24373733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
